Storia in 17 fonti

Astrazeneca explores $400bn megadeal with US rival

Astrazeneca is exploring a $400bn (£300bn) merger with US rival Bristol Myers Squibb to create one of the world's largest pharma groups

Raccontata da

www1.folha.uol.com.br

manager-magazin.de+5 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

cityam.comStai leggendo22 h fa

Astrazeneca explores $400bn megadeal with US rival

Astrazeneca is exploring a $400bn merger with Bristol Myers Squibb, creating one of the world's largest pharma groups. The deal signals Astrazeneca's North America pivot and a broader pharma consolidation wave, reshaping cross-border governance.

originale

Timeline cronologica

domenica 2 agosto 2026·www1.folha.uol.com.br
AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi
Acordo pode criar a quarta maior farmacêutica do mundo por capitalização de mercado
domenica 2 agosto 2026·handelsblatt.com
Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb
Es wäre eine der größten Fusionen in der Wirtschaftsgeschichte. Laut einem Medienbericht wurden entsprechende Gespräche geführt. Ob es zu einem Zusammenschluss kommt ist jedoch…

Astrazeneca explores $400bn megadeal with US rival

Confronto fonti

Astrazeneca explores $400bn megadeal with US rival

Timeline cronologica

AstraZeneca negocia fusão com Bristol Myers Squibb em acordo de US$ 400 bi

Pharma: AstraZeneca erwägt Mega-Fusion mit US-Rivalen Bristol Myers Squibb

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca said to have explored Bristol Myers merger | Fortune

UK's AstraZeneca eyeing $400b merger, report says

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca explora possível fusão com a Bristol Myers Squibb, diz jornal

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

Pharma giants AstraZeneca, Bristol Myers Squibb in talks on $512 billion megadeal: Report

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - AstraZeneca (NYSE:AZN)

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca said to have explored Bristol Myers merger | Fortune

An AstraZeneca-Bristol Myers megamerger? Wall Street isn’t thrilled.

Ft, AstraZeneca tratta con Bristol Myers Squibb maxi fusione da 400 miliardi

Ft: AstraZeneca tratta con Bristol Myers Squibb fusione da 400 mld

Pharma: Astra-Zeneca erwägt wohl Mega-Fusion mit Bristol-Myers Squibb

AstraZeneca: Pharmakonzern prüft 400-Milliarden-Dollar-Fusion mit Bristol Myers

AstraZeneca Held Talks to Combine With Bristol Myers Squibb, FT Says, Citing Sources

Astrazeneca explores $400bn megadeal with US rival

AstraZeneca in talks over £300bn mega-merger with US rival – reports

AstraZeneca shares drop 7% after report on $400 billion merger talks with Bristol Myers Squibb

Financial Times: 'AstraZeneca tratta con Bristol Myers Squibb per una maxi fusione da 400 miliardi' - Notizie - Ansa.it

AstraZeneca, BMS discuss $400B pharma mega-deal

AstraZeneca ‘in talks to create £300bn pharmaceutical giant’